WO2007013556A8 - 癌予防用組成物 - Google Patents

癌予防用組成物

Info

Publication number
WO2007013556A8
WO2007013556A8 PCT/JP2006/314886 JP2006314886W WO2007013556A8 WO 2007013556 A8 WO2007013556 A8 WO 2007013556A8 JP 2006314886 W JP2006314886 W JP 2006314886W WO 2007013556 A8 WO2007013556 A8 WO 2007013556A8
Authority
WO
WIPO (PCT)
Prior art keywords
cancer
prevention
composition
preventive
carcinogenesis
Prior art date
Application number
PCT/JP2006/314886
Other languages
English (en)
French (fr)
Other versions
WO2007013556A1 (ja
Inventor
Keiji Wakabayashi
Mami Takahashi
Kenji Fujii
Mitsuaki Kitano
Original Assignee
Kaneka Corp
Japan Government
Keiji Wakabayashi
Mami Takahashi
Kenji Fujii
Mitsuaki Kitano
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kaneka Corp, Japan Government, Keiji Wakabayashi, Mami Takahashi, Kenji Fujii, Mitsuaki Kitano filed Critical Kaneka Corp
Priority to JP2007526892A priority Critical patent/JPWO2007013556A1/ja
Priority to US11/997,040 priority patent/US20100150894A1/en
Priority to EP06781797A priority patent/EP1908459A4/en
Publication of WO2007013556A1 publication Critical patent/WO2007013556A1/ja
Publication of WO2007013556A8 publication Critical patent/WO2007013556A8/ja

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • A61K31/122Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15Vitamins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Abstract

本発明は、癌の予防、または癌治療後の再発防止等に有効な癌予防用組成物を得ること、または発癌予防の機能を有する医薬品、飲食品、化粧料を得ることを課題とする。 本発明者らは、補酵素Qを含有することを特徴とする組成物が発癌予防効果を有することを見いだした。
PCT/JP2006/314886 2005-07-28 2006-07-27 癌予防用組成物 WO2007013556A1 (ja)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2007526892A JPWO2007013556A1 (ja) 2005-07-28 2006-07-27 癌予防用組成物
US11/997,040 US20100150894A1 (en) 2005-07-28 2006-07-27 Composition for prevention of cancer
EP06781797A EP1908459A4 (en) 2005-07-28 2006-07-27 COMPOSITION PREVENTING CANCER

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005218833 2005-07-28
JP2005-218833 2005-07-28

Publications (2)

Publication Number Publication Date
WO2007013556A1 WO2007013556A1 (ja) 2007-02-01
WO2007013556A8 true WO2007013556A8 (ja) 2007-05-18

Family

ID=37683447

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2006/314886 WO2007013556A1 (ja) 2005-07-28 2006-07-27 癌予防用組成物

Country Status (4)

Country Link
US (1) US20100150894A1 (ja)
EP (1) EP1908459A4 (ja)
JP (1) JPWO2007013556A1 (ja)
WO (1) WO2007013556A1 (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080138326A1 (en) 2006-12-06 2008-06-12 Kaneka Corporation Method for cancer treatment, carcinogenesis suppression or mitigation of adverse reactions of anticancer agents
US9511141B2 (en) 2008-01-09 2016-12-06 Nutri Co., Ltd. Composition for reducing oxidative stress and/or side effects occurring during cancer chemotherapy or improving nutritional status during cancer chemotherapy
KR20180056816A (ko) 2009-05-11 2018-05-29 베르그 엘엘씨 환경대사적 전환인자(조효소 q10)를 사용한 질환의 치료 방법
EP2544663B1 (en) 2010-03-12 2018-01-03 Berg LLC Intravenous formulations of coenzyme q10 (coq10) and methods of use thereof
JP6092844B2 (ja) * 2011-04-04 2017-03-08 バーグ エルエルシー 中枢神経系腫瘍の治療方法
MY183615A (en) 2011-06-17 2021-03-03 Berg Llc Inhalable pharmaceutical compositions
NZ713868A (en) 2013-04-08 2021-12-24 Berg Llc Treatment of cancer using coenzyme q10 combination therapies
US11065294B2 (en) * 2013-05-15 2021-07-20 Comprehensive And Integrative Medicine Institute Composition including oriental medicine to treat neoplastic disease
SG10201907816RA (en) 2013-09-04 2019-09-27 Berg Llc Methods of treatment of cancer by continuous infusion of coenzyme q10

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6420342B1 (en) 2000-05-08 2002-07-16 N.V. Nutricia Nutritional preparation comprising ribose and medical use thereof
NL1017205C2 (nl) * 2001-01-26 2002-07-29 Adriaan Emanuel Hendricus Wiel Medicinale en cosmetische toepassing van hop en co-enzym Q10.
US6582723B2 (en) * 2001-05-03 2003-06-24 Wayne F. Gorsek Cancer immune composition for prevention and treatment of individuals
JP2003135022A (ja) 2001-10-31 2003-05-13 Crescendo Corporation コエンザイムq10
JP2004242508A (ja) * 2003-02-10 2004-09-02 Nisshin Pharma Inc コエンザイムq10および水溶性ビタミンを含有する食品
CA3031283A1 (en) * 2004-01-22 2005-08-04 University Of Miami Topical co-enzyme q10 formulations and methods of use

Also Published As

Publication number Publication date
JPWO2007013556A1 (ja) 2009-02-12
EP1908459A1 (en) 2008-04-09
EP1908459A4 (en) 2010-07-14
WO2007013556A1 (ja) 2007-02-01
US20100150894A1 (en) 2010-06-17

Similar Documents

Publication Publication Date Title
WO2007013556A8 (ja) 癌予防用組成物
WO2008124660A3 (en) Methods and compositions for the treatment of cancer
WO2006119329A3 (en) Compositions and methods for the treatment of neurodegenerative diseases
MX286273B (es) Composiciones y metodos para inhibicion de la via jak.
WO2006107451A3 (en) Honokiol derivatives for the treatment of proliferative disorders
EP1934327B8 (en) Microorganisms inhibiting the formation of axillary malodor
MX2009006536A (es) Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales.
WO2006124713A3 (en) 4-biarylyl-1-phenylazetidin-2-ones
WO2006030437A3 (en) Novel tellurium compounds and their use as immunomodulators
EP1849779A4 (en) EXTRACTED CATECHINE, METHOD FOR ITS PRODUCTION, FOOD AND BEVERAGE OR COSMETICS CONTAINING THEREOF
WO2007139871A3 (en) Methods and materials for making simvastatin and related compounds
WO2008014008A3 (en) Compositions and methods for modulating angiogenesis
WO2006078752A3 (en) Inhibitors of dna methyltransferase
WO2006073457A3 (en) Bioactive compounds and methods of uses thereof
WO2007033221A3 (en) Methods and compositions for inhibition of immune responses
PL2083809T3 (pl) Kompozycja dietetyczna lub farmaceutyczna zawierająca tricykliczne diterpeny do leczenia depresji
WO2007016419A3 (en) Methods and compositions for reducing skin damage
WO2007121125A3 (en) Hcv inhibitors
WO2007019373A3 (en) Novel formulations comprising fenofibrate and a statin, and related methods of treatment
IL187565A0 (en) Compositions and methods for the treatment or prevention of chemoresistant neoplasia
WO2007112121A3 (en) Tetracycline compounds and methods of treatment
WO2010037095A3 (en) Agents and methods for the treatment of cancer
WO2010141956A3 (en) Methods and compositions for the treatment of cancer
WO2006127368A3 (en) Methods for synthesizing imidazotriazinones
WO2010046061A3 (de) Kosmetische und/oder pharmazeutische zubereitungen

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2007526892

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2006781797

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 11997040

Country of ref document: US